Atlas开发与人类蛋白有关的抗体以及试剂,基于质谱(MS)的定量蛋白质组学,在人体中可能的20,000种蛋白质编码基因中,Atlas已经具有覆盖15,000种的基因产物,超过17,000种抗体,约13,000种蛋白质靶标。
Atlas开发与人类蛋白有关的抗体以及试剂,基于质谱(MS)的定量蛋白质组学,在人体中可能的20,000种蛋白质编码基因中,Atlas已经具有覆盖15,000种的基因产物,超过17,000种抗体,约13,000种蛋白质靶标。
At Atlas Antibodies we have a very clear mission: To provide our customers with advanced research reagents targeting all human proteins.
TheHuman Protein Atlas (HPA) project released the first version of a complete tissue-based map of human protein expression using antibodies in November 2014. In close partner ship with the HPA project, we continue to develop advanced antibodies and advanced reagents for Mass Spectrometry (MS)-based quantitative proteomics.
Of the possible 20,000 protein coding genes in the human body we already have over 18,000 antibodies covering 15,000 gene products and an additional 19,000 protein quantification MS-standards representing 13,000 protein targets. Learn more in this short film about us.
Atlas Antibodies has a very special story. The company was founded by researchers from the prestigious Human Protein Atlas project, who wanted to make the unique antibodies used in the project available to fellow researchers worldwide.
The Human Protein Atlas was initiated in 2003 by Swedish researchers, headed by Professor Mathias Uhlén, and is funded by the Knut and Alice Wallenberg foundation. It is a unique world leading effort to create a complete immunohistochemistry based map of human protein expression and localization in normal tissues, cancers and cell lines.
The project launched a first version of the complete human proteome on November 6, 2014, and plans to present a curated version finished by 2020.
产品列表:
供货商 |
产品编号 |
产品名称 |
规格 |
Atlas antibodies |
AMAb90501 |
Anti-SOX11 |
100 µl |
Atlas antibodies |
AMAb90502 |
Anti-SOX11 |
100 µl |
Atlas antibodies |
AMAb90510 |
Anti-ZEB1 |
100 µl |
Atlas antibodies |
AMAb90516 |
Anti-VIM |
100 µl |
Atlas antibodies |
AMAb90518 |
Anti-CD45 |
100 µl |
Atlas antibodies |
AMAb90519 |
Anti-CD45 |
100 µl |
Atlas antibodies |
AMAb90523 |
Anti-TG |
100 µl |
Atlas antibodies |
AMAb90525 |
Anti-CHGA |
100 µl |
Atlas antibodies |
AMAb90529 |
Anti-APOL1 |
100 µl |
Atlas antibodies |
AMAb90530 |
Anti-APOL1 |
100 µl |
Atlas antibodies |
AMAb90532 |
Anti-APOL1 |
100 µl |
Atlas antibodies |
AMAb90535 |
Anti-ADAR |
100 µl |
Atlas antibodies |
AMAb90537 |
Anti-AQP4 |
100 µl |
Atlas antibodies |
AMAb90541 |
Anti-ATAD2 |
100 µl |
Atlas antibodies |
AMAb90544 |
Anti-SIX1 |
100 µl |
Atlas antibodies |
AMAb90545 |
Anti-ARG1 |
100 µl |
Atlas antibodies |
AMAb90549 |
Anti-FUS |
100 µl |
Atlas antibodies |
AMAb90556 |
Anti-NES |
100 µl |
Atlas antibodies |
AMAb90558 |
Anti-ANXA1 |
100 µl |
Atlas antibodies |
AMAb90560 |
Anti-EMD |
100 µl |
Atlas antibodies |
AMAb90562 |
Anti-EMD |
100 µl |
Atlas antibodies |
AMAb90565 |
Anti-PCM1 |
100 µl |
Atlas antibodies |
AMAb90569 |
Anti-NLRP3 |
100 µl |
Atlas antibodies |
AMAb90572 |
Anti-SLC27A5 |
100 µl |
Atlas antibodies |
AMAb90574 |
Anti-SLC27A5 |
100 µl |
Atlas antibodies |
AMAb90575 |
Anti-SLC27A5 |
100 µl |
Atlas antibodies |
AMAb90578 |
Anti-IDH1 |
100 µl |
Atlas antibodies |
AMAb90582 |
Anti-RNASE7 |
100 µl |
Atlas antibodies |
AMAb90583 |
Anti-RNASE7 |
100 µl |
Atlas antibodies |
AMAb90584 |
Anti-FBN1 |
100 µl |
Atlas antibodies |
AMAb90585 |
Anti-FBN1 |
100 µl |
Atlas antibodies |
AMAb90591 |
Anti-RUNX2 |
100 µl |
Atlas antibodies |
AMAb90594 |
Anti-RUNX2 |
100 µl |
Atlas antibodies |
AMAb90595 |
Anti-FABP7 |
100 µl |
Atlas antibodies |
AMAb90596 |
Anti-S100A4 |
100 µl |
Atlas antibodies |
AMAb90598 |
Anti-S100A4 |
100 µl |
Atlas antibodies |
AMAb90599 |
Anti-S100A4 |
100 µl |
Atlas antibodies |
AMAb90600 |
Anti-VANGL1 |
100 µl |
Atlas antibodies |
AMAb90616 |
Anti-STX7 |
100 µl |
Atlas antibodies |
AMAb90621 |
Anti-TSPAN7 |
100 µl |
Atlas antibodies |
AMAb90624 |
Anti-TSPAN7 |
100 µl |
Atlas antibodies |
AMAb90627 |
Anti-HER2 |
100 µl |
Atlas antibodies |
AMAb90628 |
Anti-HER2 |
100 µl |
Atlas antibodies |
AMAb90630 |
Anti-SCGN |
100 µl |
Atlas antibodies |
AMAb90632 |
Anti-SCGN |
100 µl |